Acta Scientific Ophthalmology (ASOP)

Research Article Volume 3 Issue 9

Lid Hygiene Versus Lid Hygiene Plus Microblepharoexfoliation for the Treatment of Demodex folliculorumBlepharitis

Michael B. Choi, Rebecca Stein*and Henry D Perry

Cornea External Disease, Cataract and Refractive Surgery Fellow, Ophthalmic Consultants of Long Island, Rockville Centre, NY, USA

*Corresponding Author: Rebecca Stein, Cornea External Disease, Cataract and Refractive Surgery Fellow, Ophthalmic Consultants of Long Island, Rockville Centre, NY, USA.

Received: July 31, 2020; Published: August 25, 2020

×

Abstract

Purpose: To compare lid hygiene versus lid hygiene and microblepharoexfoliation (MBE) (BlephEx®) in the treatment of Demodex folliculorum blepharitis.

Methods: This study was an Institutional Review Board approved randomized prospective single masked trial of 50 patients with microscopically proven Demodex blepharitis. All subjects received lid hygiene two times a day and half were randomized to in-office MBE treatment. All subjects at baseline and one month were evaluated for the total number of Demodex on 4 eyelashes, Ocular Surface Disease Index (OSDI), tear osmolarity, MMP-9, Schirmer 1, Non-invasive tear break-up time (NIBUT), lipid layer thickness, meibography, lissamine green staining, and eyelid margin exam.

Results: The total number of Demodex decreased by 3.88 from baseline to month 1 for the lid hygiene plus MBE group vs. 0.4 for the lid hygiene alone group (p < 0.001). NIBUT increased 1.1 seconds from baseline to month 1 for the lid hygiene plus MBE group vs. 2.8 seconds for the lid hygiene alone group (p = 0.52). All other measurements were similarly not statistically significantly different (lipid layer thickness, OSDI, Osmolarity, MMP-9, Schirmer 1, meibography, lissamine green staining, and eyelid margin exam).

Conclusion: Both lid hygiene plus MBE and lid hygiene alone decreased the amount of Demodex with the group receiving MBE showing a greater decrease that was statistically significant (p < 0.001). MBE may have a positive role in the treatment of Demodex blepharitis.

Keywords: Demodex folliculorum; Lid Hygiene Plus; Dry Eye Disease

×

References

  1. Amescua G., et al. “Blepharitis Preferred Practice Pattern®”. Ophthalmology 126 (2019): P56.
  2. Lemp MA and Nichols KK. “Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment”. The Ocular Surface 7 (2009): S1-S14.
  3. Craig JP., et al. “TFOS DEWS II report executive summary”. The Ocular Surface (2017).
  4. Nichols KK., et al. “The international workshop on meibomian gland dysfunction: executive summary”. Investigative Ophthalmology and Visual Science 52 (2011): 1922-1929.
  5. Dougherty JM and McCulley JP. “Analysis of the free fatty acid component of meibomian secretions in chronic blepharitis”. Investigative Ophthalmology and Visual Science 27 (1986): 52-56.
  6. Dougherty JM and McCulley JP. “Bacterial lipases and chronic blepharitis”. Investigative Ophthalmology and Visual Science 27 (1986): 486-491.
  7. McCulley JP and Shine WE. “Meibomian secretions in chronic blepharitis”. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2: Springer (1998): 319-26.
  8. Jester J., et al. “Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD”. Investigative Ophthalmology and Visual Science 30 (1989): 936-945.
  9. Jester J., et al. “Meibomian gland dysfunction. I. Keratin protein expression in normal human and rabbit meibomian glands”. Investigative Ophthalmology and Visual Science 30 (1989): 927-935.
  10. Shimazaki J., et al. “Ocular surface changes and discomfort in patients with meibomian gland dysfunction”. Archives of ophthalmology 113 (1995): 1266-1270.
  11. Schaumberg DA., et al. “The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD”. Investigative Ophthalmology and Visual Science 52 (2011): 1994-2005.
  12. Dougherty JM and McCulley JP. “Comparative bacteriology of chronic blepharitis”. British Journal of Ophthalmology 68 (1984): 524-528.
  13. McCulley JP. “Blepharoconjunctivitis”. International Ophthalmology Clinics 24 (1984): 65-77.
  14. Ficker L., et al. “Role of cell-mediated immunity to staphylococci in blepharitis”. American Journal of Ophthalmology 111 (1991): 473-479.
  15. Rynerson JM and Perry HD. “DEBS–a unification theory for dry eye and blepharitis”. Clinical ophthalmology (Auckland, NZ) 10 (2016): 2455.
  16. Lemp MA., et al. “Association of rosacea and keratoconjunctivitis sicca”. Archives of Ophthalmology 102 (1984): 556-557.
  17. McCulley JP., et al. “Classification of chronic blepharitis”. Ophthalmology 89 (1982): 1173-1180.
  18. Czepita D., et al. “Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis”. Annales Academiae Medicae Stetinensis (2007).
  19. Gao Y-Y., et al. “High prevalence of Demodex in eyelashes with cylindrical dandruff”. Investigative Ophthalmology and Visual Science 46 (2005): 3089-3094.
  20. Tighe S., et al. “Terpinen-4-ol is the most active ingredient of tea tree oil to kill Demodex mites”. Translational Vision Science and Technology 2 (2013): 2.
  21. Holzchuh FG., et al. “Clinical treatment of ocular Demodex folliculorum by systemic ivermectin”. American Journal of Ophthalmology 151 (2011): 1030-1034. e1.
  22. Salem DA-B., et al. “Evaluation of the efficacy of oral ivermectin in comparison with ivermectin–metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum”. International Journal of Infectious Diseases 17 (2013): e343-e347.
  23. Lindsley K., et al. “Interventions for chronic blepharitis”. The Cochrane Database of Systematic Reviews 5 (2012): CD005556.
  24. Romero JM., et al. “Conservative treatment of meibomian gland dysfunction”. Eye and Contact Lens 30 (2004): 14-19.
  25. Efird J. “Blocked randomization with randomly selected block sizes”. International journal of Environmental Research and Public Health 8 (2010): 15-20.
  26. Miller KL., et al. “Minimal clinically important difference for the ocular surface disease index”. Archives of Ophthalmology 128 (2010): 94-101.
  27. Foulks GN., et al. “TearLab™ osmolarity as a biomarker for disease severity in mild to moderate dry eye disease”. American Academy of Ophthalmology (2009): PO382.
  28. Pult H and Riede-Pult B. “Comparison of subjective grading and objective assessment in meibography”. Contact Lens and Anterior Eye 36 (2013): 22-27.
  29. Bron AJ., et al. “Grading of corneal and conjunctival staining in the context of other dry eye tests”. Cornea 22 (2003): 640-650.
  30. Spickett S. “Studies on Demodex folliculorum simon (1842). I. Life history”. Parasitology 51 (1961): 181-192.
  31. Lacey N., et al. “Under the lash: Demodex mites in human diseases”. The Biochemist 31 (2009): 2.
  32. Lacey N., et al. “Demodex mites-commensals, parasites or mutualistic organisms?” Dermatology 222 (2011): 128.
  33. Lee SH., et al. “The relationship between demodex and ocular discomfort”. Investigative Ophthalmology and Visual Science 51 (2010): 2906-2911.
  34. Rufli T and Mumcuoglu Y. “The hair follicle mites Demodex folliculorum and Demodex brevis: biology and medical importance”. Dermatologica 162 (1981): 1-11.
  35. Nicholls SG., et al. “Demodex species in human ocular disease: new clinicopathological aspects”. International Ophthalmology 37 (2017): 303-312.
×

Citation

Citation: Michael B.Choi., et al. “Lid Hygiene Versus Lid Hygiene Plus Microblepharoexfoliation for the Treatment of Demodex folliculorumBlepharitis”.Acta Scientific Ophthalmology 3.9 (2020): 29-35.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 25, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US